Fred T. Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Fred T. Lee has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Susan G. Chosy
3 shared publicationsAlan H. Rappe
2 shared publicationsDavid M. Mahvi
Department of Surgery, University of Wisconsin Hospital and Clinics, 600 Highland Avenue, Madison, WI 53792
2 shared publications- Dieter Haemmerich
Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA
2 shared publications Andrew S Wright
Department of Radiology, University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA
1 shared publicationAndrew S. Wright
Department of Surgery, University of Wisconsin Hospital and Clinics, 600 Highland Avenue, Madison, WI 53792
1 shared publication
Latest Publications
- 1 November 2003
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 14 (11) , 1437-1442
Multiple Probe Radiofrequency Ablation: Pilot Study in an Animal Model
- 1 November 2003
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 14 (11) , 1437-1442
Multiple Probe Radiofrequency Ablation: Pilot Study in an Animal Model
- 1 January 2003
- Vol. 11, 144-53
Minimally invasive approaches in management of hepatic tumors.
Traditionally, the only curative option for patients with liver tumors has been hepatic resection. Unfortunately, only 10%-20% of patients with liver tumors can undergo surgical resection due to limited hepatic reserve, high surgical risk, or unfavorable tumor location. Ablation of liver tumors is currently the main alternative to formal liver resection. Tumor cell death is achieved through a number of technologies, which may be separated into three categories: chemical (percutaneous ethanol injection), cold-based (cryotherapy), and heat-based (radiofrequency and microwave ablation or laser hyperthermia). Although long-term data are limited, ablation may be curative in some patients with a three- and five-year survival rate approaching that of resection. The main factors to success include proper patient selection, excellent diagnostic and procedural imaging, and careful post-procedure management and follow up. Long-term success following tumor ablation will be most dependent on the underlying tumor biology and the ability to achieve a negative margin. Future directions in ablation will include the use of adjunctive agents such as chemotherapeutics, further advances in energy delivery, improved imaging and lesion targeting, and continued refinements of current technology and technique.
- 1 January 2003
- Vol. 11, 144-53
Minimally invasive approaches in management of hepatic tumors.
Traditionally, the only curative option for patients with liver tumors has been hepatic resection. Unfortunately, only 10%-20% of patients with liver tumors can undergo surgical resection due to limited hepatic reserve, high surgical risk, or unfavorable tumor location. Ablation of liver tumors is currently the main alternative to formal liver resection. Tumor cell death is achieved through a number of technologies, which may be separated into three categories: chemical (percutaneous ethanol injection), cold-based (cryotherapy), and heat-based (radiofrequency and microwave ablation or laser hyperthermia). Although long-term data are limited, ablation may be curative in some patients with a three- and five-year survival rate approaching that of resection. The main factors to success include proper patient selection, excellent diagnostic and procedural imaging, and careful post-procedure management and follow up. Long-term success following tumor ablation will be most dependent on the underlying tumor biology and the ability to achieve a negative margin. Future directions in ablation will include the use of adjunctive agents such as chemotherapeutics, further advances in energy delivery, improved imaging and lesion targeting, and continued refinements of current technology and technique.
- 1 June 1999
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 211 (3) , 687-692
CT-monitored Percutaneous Cryoablation in a Pig Liver Model: Pilot Study
To determine the safety and feasibility of percutaneous cryoablation with computed tomographic (CT) guidance in a pig liver model. Nine angiographic balloons (mean diameter, 9 mm) were placed in the livers of seven domestic pigs (mean weight, 30.0 kg +/- 14.0 [SD]) as tumor-mimicking lesions. By using ultrasonographic and CT guidance, two 2.4- or 3.0-mm cryoprobes were placed flanking the balloon, and a 15-20-minute freezing process was performed. Hemostasis was achieved by placing absorbable cellulose fabric down the probe tract. After 24-96 hours, animals were sacrificed, and their livers were removed and were sectioned axially at 5-mm intervals for comparison with CT images. All animals survived the procedure without complication. No serious hemorrhage was found in any case. Ice balls were readily visualized at CT because they appeared as areas of decreased attenuation (1.0 HU +/- 20.7) when compared with areas of normal liver (48.2 HU +/- 6.3, P < .05). The mean ablative margin was 1.7 cm, and only one of nine cases, the one with probe failure, had a positive margin. Beam-hardening artifact from the metal probes was present but did not interfere with the procedure. Ice-ball size and shape corresponded closely to the area of necrosis determined at histopathologic analysis. CT-monitored percutaneous cryoablation is feasible and safe in this pig liver model.
- 1 June 1999
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 211 (3) , 687-692
CT-monitored Percutaneous Cryoablation in a Pig Liver Model: Pilot Study
To determine the safety and feasibility of percutaneous cryoablation with computed tomographic (CT) guidance in a pig liver model. Nine angiographic balloons (mean diameter, 9 mm) were placed in the livers of seven domestic pigs (mean weight, 30.0 kg +/- 14.0 [SD]) as tumor-mimicking lesions. By using ultrasonographic and CT guidance, two 2.4- or 3.0-mm cryoprobes were placed flanking the balloon, and a 15-20-minute freezing process was performed. Hemostasis was achieved by placing absorbable cellulose fabric down the probe tract. After 24-96 hours, animals were sacrificed, and their livers were removed and were sectioned axially at 5-mm intervals for comparison with CT images. All animals survived the procedure without complication. No serious hemorrhage was found in any case. Ice balls were readily visualized at CT because they appeared as areas of decreased attenuation (1.0 HU +/- 20.7) when compared with areas of normal liver (48.2 HU +/- 6.3, P < .05). The mean ablative margin was 1.7 cm, and only one of nine cases, the one with probe failure, had a positive margin. Beam-hardening artifact from the metal probes was present but did not interfere with the procedure. Ice-ball size and shape corresponded closely to the area of necrosis determined at histopathologic analysis. CT-monitored percutaneous cryoablation is feasible and safe in this pig liver model.
- 30 November 1996
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 7 (6) , 889-895
Preclinical Evaluation of an Iodinated Particulate Contrast Agent for Use during Angiography: Work in Progress
- 30 November 1996
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 7 (6) , 889-895
Preclinical Evaluation of an Iodinated Particulate Contrast Agent for Use during Angiography: Work in Progress
- 31 August 1996
- Published by Elsevier in Academic Radiology
- Vol. 3, S449-S451
Iodinated triglyceride—Enhanced three-dimensional biliary imaging with helical computed tomography scanning in dogs
- 31 August 1996
- Published by Elsevier in Academic Radiology
- Vol. 3, S449-S451
Iodinated triglyceride—Enhanced three-dimensional biliary imaging with helical computed tomography scanning in dogs